PHE_Scientific - Direct award for purchase of RTPCR - Quantstudio 5 for Newborn Blood Spot Screening Evaluation for SCID
Public Health England has awarded a contract to Life Technologies Ltd for provision of purchase of RTPCR - Quantstudio 5 instruments. under Lot 1 of PHE Microbiology Framework via Direct-award for evaluation study of New Born Blood Spot Screening Programme (NBS).
Buyer
Public Health England
Value
£405,000
Published
21 Feb 2020
Closes
18 Feb 2020
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Selective
Category
Goods
Contract starts
19 Feb 2020
Contract ends
31 Aug 2023
CPV classifications
38950000
Polymerase Chain Reaction (PCR) equipment
Lots
Lot default PHE_Scientific - Direct award for purchase of RTPCR - Quantstudio 5 for Newborn Blood Spot Screening Evaluation for SCID
£405,000
Public Health England has awarded a contract to Life Technologies Ltd for provision of purchase of RTPCR - Quantstudio 5 instruments. under Lot 1 of PHE Microbiology Framework via Direct-award for evaluation study of New Born Blood Spot Screening Programme (NBS).
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
21 Feb 2020
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.